Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Voss

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Journal of Virology|December 28, 2002
Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccineGerald Voss, Kelledy Manson, David Montefiori, et al.
F1000Research|March 24, 2018
Progress and challenges in TB vaccine developmentGerald Voss, Danilo Casimiro, Olivier Neyrolles, et al.
The Journal of General Virology|February 19, 2009
Acute-phase CD4+ T-cell proliferation and CD152 upregulation predict set-point virus replication in vaccinated simian-human immunodeficiency virus strain 89.6p-infected macaquesGerrit Koopman, Daniella Mortier, Sam Hofman, et al.
Plos One|October 28, 2024
The TB vaccine clinical trial centre directory: An inventory of clinical trial centres in Sub-Saharan AfricaPuck T Pelzer, Marit Holleman, Michelle E H Helinski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gammaPeifang Sun, Robert Schwenk, Katherine White, et al.
Plos One|December 11, 2012
Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccineRichard Stebbings, Michèle Février, Bo Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2011
An adjuvanted polyprotein HIV-1 vaccine induces polyfunctional cross-reactive CD4+ T cell responses in seronegative volunteersEva Van Braeckel, Patricia Bourguignon, Marguerite Koutsoukos, et al.
Frontiers in Medicine|June 17, 2022
Preparing for Disease X: Ensuring Vaccine Equity for Pregnant Women in Future PandemicsFlor M Munoz, Clare L Cutland, Christine E Jones, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 18, 2012
Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaquesClarisse Lorin, Lawrence Segal, Johann Mols, et al.
The Journal of General Virology|January 17, 2008
Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian-human immunodeficiency virus viraemia with protein/DNA combinationGerrit Koopman, Daniella Mortier, Sam Hofman, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Journal of Virology|December 28, 2002
Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccineGerald Voss, Kelledy Manson, David Montefiori, et al.
F1000Research|March 24, 2018
Progress and challenges in TB vaccine developmentGerald Voss, Danilo Casimiro, Olivier Neyrolles, et al.
The Journal of General Virology|February 19, 2009
Acute-phase CD4+ T-cell proliferation and CD152 upregulation predict set-point virus replication in vaccinated simian-human immunodeficiency virus strain 89.6p-infected macaquesGerrit Koopman, Daniella Mortier, Sam Hofman, et al.
Plos One|October 28, 2024
The TB vaccine clinical trial centre directory: An inventory of clinical trial centres in Sub-Saharan AfricaPuck T Pelzer, Marit Holleman, Michelle E H Helinski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gammaPeifang Sun, Robert Schwenk, Katherine White, et al.
Plos One|December 11, 2012
Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccineRichard Stebbings, Michèle Février, Bo Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2011
An adjuvanted polyprotein HIV-1 vaccine induces polyfunctional cross-reactive CD4+ T cell responses in seronegative volunteersEva Van Braeckel, Patricia Bourguignon, Marguerite Koutsoukos, et al.
Frontiers in Medicine|June 17, 2022
Preparing for Disease X: Ensuring Vaccine Equity for Pregnant Women in Future PandemicsFlor M Munoz, Clare L Cutland, Christine E Jones, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 18, 2012
Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaquesClarisse Lorin, Lawrence Segal, Johann Mols, et al.
The Journal of General Virology|January 17, 2008
Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian-human immunodeficiency virus viraemia with protein/DNA combinationGerrit Koopman, Daniella Mortier, Sam Hofman, et al.
Pageof 5